A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

scientific article published on 04 September 2019

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12885-019-6097-Z
P932PMC publication ID6727408
P698PubMed publication ID31484505

P50authorDirk VerellenQ77648055
Carole MercierQ93103631
P2093author name stringPiet Ost
Yolande Lievens
Piet Dirix
Peter Vermeulen
Charlotte Billiet
Ines Joye
P2860cites workVertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic scoreQ44237488
Vertebral Compression Fracture After Spine Stereotactic Body Radiation Therapy: A Review of the Pathophysiology and Risk FactorsQ47640737
A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapyQ47754559
ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer.Q48622865
Update of the systematic review of palliative radiation therapy fractionation for bone metastasesQ49352551
Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study.Q53589962
Pain flare after stereotactic radiosurgery for spine metastases.Q55273981
A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial)Q58736621
Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trialsQ85322617
Pain flare is a common adverse event in steroid-naïve patients after spine stereotactic body radiation therapy: a prospective clinical trialQ86761912
Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastasesQ88506308
Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapyQ88908967
Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013Q26786454
Stereotactic body radiation therapy: the report of AAPM Task Group 101.Q30451917
Stereotactic body radiotherapy for spinal and bone metastasesQ33275551
Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinomaQ33668241
Pain flare in patients with bone metastases after palliative radiotherapy--a nested randomized control trialQ34000809
Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis.Q34149093
Missing data in clinical studies: issues and methodsQ34287191
Innovations in image-guided radiotherapy.Q34717651
Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic reviewQ34766450
Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastasesQ35190502
Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials.Q35754868
Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study.Q35795558
A definition of "uncomplicated bone metastases" based on previous bone metastases radiation trials comparing single-fraction and multi-fraction radiation therapyQ36207581
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)Q36377961
Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastasesQ36875395
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled TrialQ36914459
Stereotactic body radiosurgery for spinal metastases: a critical reviewQ37178330
A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study GroupQ37766425
Electronic patient-reported outcome systems in oncology clinical practiceQ38027463
Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trialQ38414707
Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancerQ38620435
Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline.Q39166964
Pain control by image-guided radiosurgery for solitary spinal metastasisQ39324710
Patient-reported outcomes questionnaire compliance in Cancer Cooperative Group Trials (Alliance N0992).Q39640851
Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastasesQ39761010
Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck CancerQ39791477
P433issue1
P921main subjectphase III clinical trialQ42824827
P304page(s)876
P577publication date2019-09-04
P1433published inBMC CancerQ326300
P1476titleA phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
P478volume19